News Focus
News Focus
icon url

West Coast Snapper

06/04/13 5:26 AM

#11654 RE: NukeJohn #11653

Now that's the type of article is love to read on seeking alpha :). That's something that adds value
icon url

Thales622

06/04/13 9:45 AM

#11656 RE: NukeJohn #11653

None of those trials will move the stock from a professional's point of view unless they are double blind placebo controlled trials.

Unless the trials are designed like that the studies have no more value than hearsay basically. They aren't valid scientifically.

Might be useful for marketing, but thats about it.

I've invested in biotechs before, thats how I know.

Some info here:

http://www.winchesterhospital.org/health-library/article?id=38405
icon url

Regis999

06/04/13 10:30 AM

#11659 RE: NukeJohn #11653

Potential Catalysts NJ

Introduction of E Cig with anatabine.

I am very surprised this has yet to happen. It would distinguish one from another. It would become the most popular E cig.
icon url

uptick77777

06/04/13 2:40 PM

#11672 RE: NukeJohn #11653

To your point #15 ---------

In Nov. 2012 this 13G was filed:

"In a 13G filing on Star Scientific, Inc. (Nasdaq: STSI), John Joseph McKeon disclosed a 8.20%, or 13,673,454 share, stake in the company."

http://www.streetinsider.com/13Gs/John+J.+McKeon+Takes+8.2%25+Stake+in+Star+Scientific+(STSI)/7914444.html


Unfortunately, this news did not cause a short squeeze.

At the time, no one seemed to know who John McKeon was, nor his connection to STSI / Anatabine or his motivation for acquiring such a large block of STSI stock.

Has anyone developed any intelligent on the who, what, why, etc. on John McKeon's position in STSI?

BTW: John McKeon's business address on the 13G was given as 2630 Harbourside Dr., Longboat Key, FL 34228.